As the curtain falls on the 44th edition of the J.P. Morgan Healthcare Conference in San Francisco, a medtech company CEO ...

VB Spine has agreed to acquire the SpineHawk intraoperative spinal visualisation platform from Robotron Surgical Technologies ...

BD has received 510(k) approval from the US FDA for the EnCor EnCompass breast biopsy and tissue removal system.

Despite launching the newest iQ3 device, Butterfly’s second-generation POCUS, the iQ+, remains available as the most ...

Two of Opus's seven gene therapy assets are in clinical trials, with additional programs expected to enter the clinic.

Rakuten’s strategy, central to which is photoimmunotherapy, aligns with a shift toward platform-based medtech models.

Boston Scientific has agreed to acquire Penumbra in a deal worth around $14.5bn, a move that will expand the medtech giant’s ...

Tempus AI CEO Eric Lefkofsky presented at the JP Morgan Healthcare Conference to discuss how the company is practising ...

Zimmer Biomet announced plans to continue developing its robotic platforms and investing in a stronger, specialised sales ...

Robotic surgery giant Intuitive’s stock has fallen despite reporting positive growth in its full year 2025 (FY25) and Q4 ...

During the J.P. Morgan Healthcare Conference in San Francisco, Insulet displayed revenue growth at a compound annual growth ...

Broad adoption of single-use endoscopes fuels strong growth projections for Danish developer Ambu through 2030.